The global market for Hepatocyte Growth Factor was estimated to be worth US$ 45 million in 2023 and is forecast to a readjusted size of US$ 287.9 million by 2030 with a CAGR of 30.0% during the forecast period 2024-2030

Hepatocyte Growth Factor - Market

Hepatocyte growth factor (HGF) (or scatter factor (SF) is a paracrine cellular growth, motility and morphogenic factor. It is secreted by mesenchymal cells and targets and acts primarily upon epithelial cells and endothelial cells, but also acts on haemopoietic progenitor cells and T cells. It has been shown to have a major role in embryonic organ development, specifically in myogenesis, in adult organ regeneration, and in wound healing.

Asia Pacific will be the largest region of Hepatocyte Growth Factor, which will occupy about 60% market share in 2030. North America will be the second largest market with the consumption market share of 25% in 2030. ViroMed, AnGes MG, M3 Biotechnology, AVEO Pharmaceuticals, Molecular Partners and Yooyoung Pharm are the major manufacturers of industry.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Hepatocyte Growth Factor, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Hepatocyte Growth Factor by region & country, by Type, and by Application.

The Hepatocyte Growth Factor market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatocyte Growth Factor.

Market Segmentation

Scope of Hepatocyte Growth Factor - Market Report

Report Metric	Details
Report Name	Hepatocyte Growth Factor - Market
Forecasted market size in 2030	US$ 287.9 million
CAGR	30.0%
Forecasted years	2024 - 2030
Segment by Type:	Phase III (Ongoing) Phase II (Approved) Phase II (Ongoing) Phase 1 Preclinical
Segment by Application	Oncology Cardiovascular Central Nervous System Hematological Disorders Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	ViroMed, AnGes MG, M3 Biotechnology, AVEO Pharmaceuticals, Molecular Partners, Yooyoung Pharm, F-star, Galaxy Biotech, Kringle Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Hepatocyte Growth Factor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Hepatocyte Growth Factor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Hepatocyte Growth Factor in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Hepatocyte Growth Factor - Market size in 2030?

Ans: The Hepatocyte Growth Factor - Market size in 2030 will be US$ 287.9 million.

What is the Hepatocyte Growth Factor - Market share by region?

Ans: North America will be the second largest market with the consumption market share of 25% in 2030.

Who are the main players in the Hepatocyte Growth Factor - Market report?

Ans: The main players in the Hepatocyte Growth Factor - Market are ViroMed, AnGes MG, M3 Biotechnology, AVEO Pharmaceuticals, Molecular Partners, Yooyoung Pharm, F-star, Galaxy Biotech, Kringle Pharma

What are the Application segmentation covered in the Hepatocyte Growth Factor - Market report?

Ans: The Applications covered in the Hepatocyte Growth Factor - Market report are Oncology, Cardiovascular, Central Nervous System, Hematological Disorders, Others

What are the Type segmentation covered in the Hepatocyte Growth Factor - Market report?

Ans: The Types covered in the Hepatocyte Growth Factor - Market report are Phase III (Ongoing), Phase II (Approved), Phase II (Ongoing), Phase 1, Preclinical

1 Market Overview

1.1 Hepatocyte Growth Factor Product Introduction

1.2 Global Hepatocyte Growth Factor Market Size Forecast

1.2.1 Global Hepatocyte Growth Factor Sales Value (2019-2030)

1.2.2 Global Hepatocyte Growth Factor Sales Volume (2019-2030)

1.2.3 Global Hepatocyte Growth Factor Sales Price (2019-2030)

1.3 Hepatocyte Growth Factor Market Trends & Drivers

1.3.1 Hepatocyte Growth Factor Industry Trends

1.3.2 Hepatocyte Growth Factor Market Drivers & Opportunity

1.3.3 Hepatocyte Growth Factor Market Challenges

1.3.4 Hepatocyte Growth Factor Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Hepatocyte Growth Factor Players Revenue Ranking (2023)

2.2 Global Hepatocyte Growth Factor Revenue by Company (2019-2024)

2.3 Global Hepatocyte Growth Factor Players Sales Volume Ranking (2023)

2.4 Global Hepatocyte Growth Factor Sales Volume by Company Players (2019-2024)

2.5 Global Hepatocyte Growth Factor Average Price by Company (2019-2024)

2.6 Key Manufacturers Hepatocyte Growth Factor Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Hepatocyte Growth Factor Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Hepatocyte Growth Factor

2.9 Hepatocyte Growth Factor Market Competitive Analysis

2.9.1 Hepatocyte Growth Factor Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Hepatocyte Growth Factor Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatocyte Growth Factor as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Phase III (Ongoing)

3.1.2 Phase II (Approved)

3.1.3 Phase II (Ongoing)

3.1.4 Phase 1

3.1.5 Preclinical

3.2 Global Hepatocyte Growth Factor Sales Value by Type

3.2.1 Global Hepatocyte Growth Factor Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Hepatocyte Growth Factor Sales Value, by Type (2019-2030)

3.2.3 Global Hepatocyte Growth Factor Sales Value, by Type (%) (2019-2030)

3.3 Global Hepatocyte Growth Factor Sales Volume by Type

3.3.1 Global Hepatocyte Growth Factor Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Hepatocyte Growth Factor Sales Volume, by Type (2019-2030)

3.3.3 Global Hepatocyte Growth Factor Sales Volume, by Type (%) (2019-2030)

3.4 Global Hepatocyte Growth Factor Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Oncology

4.1.2 Cardiovascular

4.1.3 Central Nervous System

4.1.4 Hematological Disorders

4.1.5 Others

4.2 Global Hepatocyte Growth Factor Sales Value by Application

4.2.1 Global Hepatocyte Growth Factor Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Hepatocyte Growth Factor Sales Value, by Application (2019-2030)

4.2.3 Global Hepatocyte Growth Factor Sales Value, by Application (%) (2019-2030)

4.3 Global Hepatocyte Growth Factor Sales Volume by Application

4.3.1 Global Hepatocyte Growth Factor Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Hepatocyte Growth Factor Sales Volume, by Application (2019-2030)

4.3.3 Global Hepatocyte Growth Factor Sales Volume, by Application (%) (2019-2030)

4.4 Global Hepatocyte Growth Factor Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Hepatocyte Growth Factor Sales Value by Region

5.1.1 Global Hepatocyte Growth Factor Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Hepatocyte Growth Factor Sales Value by Region (2019-2024)

5.1.3 Global Hepatocyte Growth Factor Sales Value by Region (2025-2030)

5.1.4 Global Hepatocyte Growth Factor Sales Value by Region (%), (2019-2030)

5.2 Global Hepatocyte Growth Factor Sales Volume by Region

5.2.1 Global Hepatocyte Growth Factor Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Hepatocyte Growth Factor Sales Volume by Region (2019-2024)

5.2.3 Global Hepatocyte Growth Factor Sales Volume by Region (2025-2030)

5.2.4 Global Hepatocyte Growth Factor Sales Volume by Region (%), (2019-2030)

5.3 Global Hepatocyte Growth Factor Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Hepatocyte Growth Factor Sales Value, 2019-2030

5.4.2 North America Hepatocyte Growth Factor Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Hepatocyte Growth Factor Sales Value, 2019-2030

5.5.2 Europe Hepatocyte Growth Factor Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Hepatocyte Growth Factor Sales Value, 2019-2030

5.6.2 Asia Pacific Hepatocyte Growth Factor Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Hepatocyte Growth Factor Sales Value, 2019-2030

5.7.2 South America Hepatocyte Growth Factor Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Hepatocyte Growth Factor Sales Value, 2019-2030

5.8.2 Middle East & Africa Hepatocyte Growth Factor Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Hepatocyte Growth Factor Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Hepatocyte Growth Factor Sales Value

6.2.1 Key Countries/Regions Hepatocyte Growth Factor Sales Value, 2019-2030

6.2.2 Key Countries/Regions Hepatocyte Growth Factor Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Hepatocyte Growth Factor Sales Value, 2019-2030

6.3.2 United States Hepatocyte Growth Factor Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Hepatocyte Growth Factor Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Hepatocyte Growth Factor Sales Value, 2019-2030

6.4.2 Europe Hepatocyte Growth Factor Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Hepatocyte Growth Factor Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Hepatocyte Growth Factor Sales Value, 2019-2030

6.5.2 China Hepatocyte Growth Factor Sales Value by Type (%), 2023 VS 2030

6.5.3 China Hepatocyte Growth Factor Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Hepatocyte Growth Factor Sales Value, 2019-2030

6.6.2 Japan Hepatocyte Growth Factor Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Hepatocyte Growth Factor Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Hepatocyte Growth Factor Sales Value, 2019-2030

6.7.2 South Korea Hepatocyte Growth Factor Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Hepatocyte Growth Factor Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Hepatocyte Growth Factor Sales Value, 2019-2030

6.8.2 Southeast Asia Hepatocyte Growth Factor Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Hepatocyte Growth Factor Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Hepatocyte Growth Factor Sales Value, 2019-2030

6.9.2 India Hepatocyte Growth Factor Sales Value by Type (%), 2023 VS 2030

6.9.3 India Hepatocyte Growth Factor Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 ViroMed

7.1.1 ViroMed Company Information

7.1.2 ViroMed Introduction and Business Overview

7.1.3 ViroMed Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2019-2024)

7.1.4 ViroMed Hepatocyte Growth Factor Product Offerings

7.1.5 ViroMed Recent Development

7.2 AnGes MG

7.2.1 AnGes MG Company Information

7.2.2 AnGes MG Introduction and Business Overview

7.2.3 AnGes MG Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2019-2024)

7.2.4 AnGes MG Hepatocyte Growth Factor Product Offerings

7.2.5 AnGes MG Recent Development

7.3 M3 Biotechnology

7.3.1 M3 Biotechnology Company Information

7.3.2 M3 Biotechnology Introduction and Business Overview

7.3.3 M3 Biotechnology Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2019-2024)

7.3.4 M3 Biotechnology Hepatocyte Growth Factor Product Offerings

7.3.5 M3 Biotechnology Recent Development

7.4 AVEO Pharmaceuticals

7.4.1 AVEO Pharmaceuticals Company Information

7.4.2 AVEO Pharmaceuticals Introduction and Business Overview

7.4.3 AVEO Pharmaceuticals Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2019-2024)

7.4.4 AVEO Pharmaceuticals Hepatocyte Growth Factor Product Offerings

7.4.5 AVEO Pharmaceuticals Recent Development

7.5 Molecular Partners

7.5.1 Molecular Partners Company Information

7.5.2 Molecular Partners Introduction and Business Overview

7.5.3 Molecular Partners Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Molecular Partners Hepatocyte Growth Factor Product Offerings

7.5.5 Molecular Partners Recent Development

7.6 Yooyoung Pharm

7.6.1 Yooyoung Pharm Company Information

7.6.2 Yooyoung Pharm Introduction and Business Overview

7.6.3 Yooyoung Pharm Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Yooyoung Pharm Hepatocyte Growth Factor Product Offerings

7.6.5 Yooyoung Pharm Recent Development

7.7 F-star

7.7.1 F-star Company Information

7.7.2 F-star Introduction and Business Overview

7.7.3 F-star Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2019-2024)

7.7.4 F-star Hepatocyte Growth Factor Product Offerings

7.7.5 F-star Recent Development

7.8 Galaxy Biotech

7.8.1 Galaxy Biotech Company Information

7.8.2 Galaxy Biotech Introduction and Business Overview

7.8.3 Galaxy Biotech Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Galaxy Biotech Hepatocyte Growth Factor Product Offerings

7.8.5 Galaxy Biotech Recent Development

7.9 Kringle Pharma

7.9.1 Kringle Pharma Company Information

7.9.2 Kringle Pharma Introduction and Business Overview

7.9.3 Kringle Pharma Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Kringle Pharma Hepatocyte Growth Factor Product Offerings

7.9.5 Kringle Pharma Recent Development

8 Industry Chain Analysis

8.1 Hepatocyte Growth Factor Industrial Chain

8.2 Hepatocyte Growth Factor Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Hepatocyte Growth Factor Sales Model

8.5.2 Sales Channel

8.5.3 Hepatocyte Growth Factor Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Hepatocyte Growth Factor Market Trends

Table 2. Hepatocyte Growth Factor Market Drivers & Opportunity

Table 3. Hepatocyte Growth Factor Market Challenges

Table 4. Hepatocyte Growth Factor Market Restraints

Table 5. Global Hepatocyte Growth Factor Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Hepatocyte Growth Factor Revenue Market Share by Company (2019-2024)

Table 7. Global Hepatocyte Growth Factor Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Hepatocyte Growth Factor Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Hepatocyte Growth Factor Price by Company (2019-2024) & (USD/Unit)

Table 10. Key Manufacturers Hepatocyte Growth Factor Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Hepatocyte Growth Factor Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Hepatocyte Growth Factor

Table 13. Global Hepatocyte Growth Factor Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatocyte Growth Factor as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Hepatocyte Growth Factor Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Hepatocyte Growth Factor Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Hepatocyte Growth Factor Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Hepatocyte Growth Factor Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Hepatocyte Growth Factor Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Hepatocyte Growth Factor Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Hepatocyte Growth Factor Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Hepatocyte Growth Factor Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Hepatocyte Growth Factor Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Hepatocyte Growth Factor Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Hepatocyte Growth Factor Price by Type (2019-2024) & (USD/Unit)

Table 27. Global Hepatocyte Growth Factor Price by Type (2025-2030) & (USD/Unit)

Table 28. Global Hepatocyte Growth Factor Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Hepatocyte Growth Factor Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Hepatocyte Growth Factor Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Hepatocyte Growth Factor Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Hepatocyte Growth Factor Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Hepatocyte Growth Factor Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Hepatocyte Growth Factor Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Hepatocyte Growth Factor Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Hepatocyte Growth Factor Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Hepatocyte Growth Factor Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Hepatocyte Growth Factor Price by Application (2019-2024) & (USD/Unit)

Table 39. Global Hepatocyte Growth Factor Price by Application (2025-2030) & (USD/Unit)

Table 40. Global Hepatocyte Growth Factor Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Hepatocyte Growth Factor Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Hepatocyte Growth Factor Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Hepatocyte Growth Factor Sales Value by Region (2019-2024) & (%)

Table 44. Global Hepatocyte Growth Factor Sales Value by Region (2025-2030) & (%)

Table 45. Global Hepatocyte Growth Factor Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Hepatocyte Growth Factor Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Hepatocyte Growth Factor Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Hepatocyte Growth Factor Sales Volume by Region (2019-2024) & (%)

Table 49. Global Hepatocyte Growth Factor Sales Volume by Region (2025-2030) & (%)

Table 50. Global Hepatocyte Growth Factor Average Price by Region (2019-2024) & (USD/Unit)

Table 51. Global Hepatocyte Growth Factor Average Price by Region (2025-2030) & (USD/Unit)

Table 52. Key Countries/Regions Hepatocyte Growth Factor Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Hepatocyte Growth Factor Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Hepatocyte Growth Factor Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Hepatocyte Growth Factor Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Hepatocyte Growth Factor Sales Volume, (2025-2030) & (K Units)

Table 57. ViroMed Company Information

Table 58. ViroMed Introduction and Business Overview

Table 59. ViroMed Hepatocyte Growth Factor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 60. ViroMed Hepatocyte Growth Factor Product Offerings

Table 61. ViroMed Recent Development

Table 62. AnGes MG Company Information

Table 63. AnGes MG Introduction and Business Overview

Table 64. AnGes MG Hepatocyte Growth Factor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 65. AnGes MG Hepatocyte Growth Factor Product Offerings

Table 66. AnGes MG Recent Development

Table 67. M3 Biotechnology Company Information

Table 68. M3 Biotechnology Introduction and Business Overview

Table 69. M3 Biotechnology Hepatocyte Growth Factor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 70. M3 Biotechnology Hepatocyte Growth Factor Product Offerings

Table 71. M3 Biotechnology Recent Development

Table 72. AVEO Pharmaceuticals Company Information

Table 73. AVEO Pharmaceuticals Introduction and Business Overview

Table 74. AVEO Pharmaceuticals Hepatocyte Growth Factor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 75. AVEO Pharmaceuticals Hepatocyte Growth Factor Product Offerings

Table 76. AVEO Pharmaceuticals Recent Development

Table 77. Molecular Partners Company Information

Table 78. Molecular Partners Introduction and Business Overview

Table 79. Molecular Partners Hepatocyte Growth Factor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 80. Molecular Partners Hepatocyte Growth Factor Product Offerings

Table 81. Molecular Partners Recent Development

Table 82. Yooyoung Pharm Company Information

Table 83. Yooyoung Pharm Introduction and Business Overview

Table 84. Yooyoung Pharm Hepatocyte Growth Factor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 85. Yooyoung Pharm Hepatocyte Growth Factor Product Offerings

Table 86. Yooyoung Pharm Recent Development

Table 87. F-star Company Information

Table 88. F-star Introduction and Business Overview

Table 89. F-star Hepatocyte Growth Factor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 90. F-star Hepatocyte Growth Factor Product Offerings

Table 91. F-star Recent Development

Table 92. Galaxy Biotech Company Information

Table 93. Galaxy Biotech Introduction and Business Overview

Table 94. Galaxy Biotech Hepatocyte Growth Factor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 95. Galaxy Biotech Hepatocyte Growth Factor Product Offerings

Table 96. Galaxy Biotech Recent Development

Table 97. Kringle Pharma Company Information

Table 98. Kringle Pharma Introduction and Business Overview

Table 99. Kringle Pharma Hepatocyte Growth Factor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 100. Kringle Pharma Hepatocyte Growth Factor Product Offerings

Table 101. Kringle Pharma Recent Development

Table 102. Key Raw Materials Lists

Table 103. Raw Materials Key Suppliers Lists

Table 104. Hepatocyte Growth Factor Downstream Customers

Table 105. Hepatocyte Growth Factor Distributors List

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

List of Figures

Figure 1. Hepatocyte Growth Factor Product Picture

Figure 2. Global Hepatocyte Growth Factor Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Hepatocyte Growth Factor Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Hepatocyte Growth Factor Sales Volume (2019-2030) & (K Units)

Figure 5. Global Hepatocyte Growth Factor Sales Price (2019-2030) & (USD/Unit)

Figure 6. Hepatocyte Growth Factor Report Years Considered

Figure 7. Global Hepatocyte Growth Factor Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Hepatocyte Growth Factor Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Hepatocyte Growth Factor Revenue in 2023

Figure 10. Hepatocyte Growth Factor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Phase III (Ongoing) Picture

Figure 12. Phase II (Approved) Picture

Figure 13. Phase II (Ongoing) Picture

Figure 14. Phase 1 Picture

Figure 15. Preclinical Picture

Figure 16. Global Hepatocyte Growth Factor Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 17. Global Hepatocyte Growth Factor Sales Value Market Share by Type, 2023 & 2030

Figure 18. Global Hepatocyte Growth Factor Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 19. Global Hepatocyte Growth Factor Sales Volume Market Share by Type, 2023 & 2030

Figure 20. Global Hepatocyte Growth Factor Price by Type (2019-2030) & (USD/Unit)

Figure 21. Product Picture of Oncology

Figure 22. Product Picture of Cardiovascular

Figure 23. Product Picture of Central Nervous System

Figure 24. Product Picture of Hematological Disorders

Figure 25. Product Picture of Others

Figure 26. Global Hepatocyte Growth Factor Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 27. Global Hepatocyte Growth Factor Sales Value Market Share by Application, 2023 & 2030

Figure 28. Global Hepatocyte Growth Factor Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 29. Global Hepatocyte Growth Factor Sales Volume Market Share by Application, 2023 & 2030

Figure 30. Global Hepatocyte Growth Factor Price by Application (2019-2030) & (USD/Unit)

Figure 31. North America Hepatocyte Growth Factor Sales Value (2019-2030) & (US$ Million)

Figure 32. North America Hepatocyte Growth Factor Sales Value by Country (%), 2023 VS 2030

Figure 33. Europe Hepatocyte Growth Factor Sales Value (2019-2030) & (US$ Million)

Figure 34. Europe Hepatocyte Growth Factor Sales Value by Country (%), 2023 VS 2030

Figure 35. Asia Pacific Hepatocyte Growth Factor Sales Value (2019-2030) & (US$ Million)

Figure 36. Asia Pacific Hepatocyte Growth Factor Sales Value by Country (%), 2023 VS 2030

Figure 37. South America Hepatocyte Growth Factor Sales Value (2019-2030) & (US$ Million)

Figure 38. South America Hepatocyte Growth Factor Sales Value by Country (%), 2023 VS 2030

Figure 39. Middle East & Africa Hepatocyte Growth Factor Sales Value (2019-2030) & (US$ Million)

Figure 40. Middle East & Africa Hepatocyte Growth Factor Sales Value by Country (%), 2023 VS 2030

Figure 41. Key Countries/Regions Hepatocyte Growth Factor Sales Value (%), (2019-2030)

Figure 42. Key Countries/Regions Hepatocyte Growth Factor Sales Volume (%), (2019-2030)

Figure 43. United States Hepatocyte Growth Factor Sales Value, (2019-2030) & (US$ Million)

Figure 44. United States Hepatocyte Growth Factor Sales Value by Type (%), 2023 VS 2030

Figure 45. United States Hepatocyte Growth Factor Sales Value by Application (%), 2023 VS 2030

Figure 46. Europe Hepatocyte Growth Factor Sales Value, (2019-2030) & (US$ Million)

Figure 47. Europe Hepatocyte Growth Factor Sales Value by Type (%), 2023 VS 2030

Figure 48. Europe Hepatocyte Growth Factor Sales Value by Application (%), 2023 VS 2030

Figure 49. China Hepatocyte Growth Factor Sales Value, (2019-2030) & (US$ Million)

Figure 50. China Hepatocyte Growth Factor Sales Value by Type (%), 2023 VS 2030

Figure 51. China Hepatocyte Growth Factor Sales Value by Application (%), 2023 VS 2030

Figure 52. Japan Hepatocyte Growth Factor Sales Value, (2019-2030) & (US$ Million)

Figure 53. Japan Hepatocyte Growth Factor Sales Value by Type (%), 2023 VS 2030

Figure 54. Japan Hepatocyte Growth Factor Sales Value by Application (%), 2023 VS 2030

Figure 55. South Korea Hepatocyte Growth Factor Sales Value, (2019-2030) & (US$ Million)

Figure 56. South Korea Hepatocyte Growth Factor Sales Value by Type (%), 2023 VS 2030

Figure 57. South Korea Hepatocyte Growth Factor Sales Value by Application (%), 2023 VS 2030

Figure 58. Southeast Asia Hepatocyte Growth Factor Sales Value, (2019-2030) & (US$ Million)

Figure 59. Southeast Asia Hepatocyte Growth Factor Sales Value by Type (%), 2023 VS 2030

Figure 60. Southeast Asia Hepatocyte Growth Factor Sales Value by Application (%), 2023 VS 2030

Figure 61. India Hepatocyte Growth Factor Sales Value, (2019-2030) & (US$ Million)

Figure 62. India Hepatocyte Growth Factor Sales Value by Type (%), 2023 VS 2030

Figure 63. India Hepatocyte Growth Factor Sales Value by Application (%), 2023 VS 2030

Figure 64. Hepatocyte Growth Factor Industrial Chain

Figure 65. Hepatocyte Growth Factor Manufacturing Cost Structure

Figure 66. Channels of Distribution (Direct Sales, and Distribution)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions